Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial

Bibliographic Details
Title: Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
Authors: Powles, Thomas, Atkins, Michael B., Escudier, Bernard, Motzer, Robert J., Rini, Brian I., Fong, Lawrence, Joseph, Richard W., Pal, Sumanta K., Sznol, Mario, Hainsworth, John, Stadler, Walter M., Hutson, Thomas E., Ravaud, Alain, Bracarda, Sergio, Suarez, Cristina, Choueiri, Toni K., Reeves, James, Cohn, Allen, Ding, Beiying, Leng, Ning, Hashimoto, Kenji, Huseni, Mahrukh, Schiff, Christina, McDermott, David F.
Source: In European Urology May 2021 79(5):665-673
Database: ScienceDirect
More Details
ISSN:03022838
DOI:10.1016/j.eururo.2021.01.003
Published in:European Urology
Language:English